Femtech startup Inne takes the wraps off a hormone tracker and $8.8M in funding
Post date: 2019-10-31 20:00:45
Views: 469
Berlin-based femtech startup Inne is coming out of stealth to announce an €8 million (~$8.8M) Series A and give the first glimpse of a hormone-tracking subscription product for fertility-tracking and natural contraception that’s slated for launch in Q1 next year. The Series A is led by led by Blossom Capital, with early Inne backer Monkfish
Please click Here to read the full story.
 
Other Top and Latest Questions:
Bill Ackman built Microsoft stake in first quarter during sell-off, betting on AI and cloud growth
Jim Cramer fears SpaceX's IPO could be 'destructive' for the rest of market
Stocks like Nvidia have accelerating 'momentum,' Goldman Sachs says
Wall Street and Main Street face off next week with Nvidia, consumer earnings. Here's what's ahead 
How to plan a trip for medical tourism and the best resources
Russia's Putin to meet China's Xi in Beijing from May 19-20, Beijing and Moscow say
Cerebras' blockbuster IPO boosts hype for SpaceX and OpenAI, but crowds out smaller players
What you need to know about Nvidia competitor Cerebras after wild IPO
What are the current weather conditions in northern BC, AB, or SK?
Fellow Californians, How are You Handling the Governor Primary?